Chrysophanol improves memory ability of D-galactose and Aβ25–35 treated rat correlating with inhibiting tau hyperphosphorylation and the CaM–CaMKIV signal pathway in hippocampus
2020
Ye, Ting | Li, Xinquan | Zhou, Peng | Ye, S. (Shu) | Gao, Huawu | Hua, Rupeng | Ma, Junlong | Wang, Yan | Cai, Biao
This study was aimed to investigate the effect of Chrysophanol (CHR) on Alzheimer’s disease. We also attempted to understand the potential mechanisms. An Alzheimer’s disease rat model was established using an intraperitoneal injection of D-galactose combined with an intracerebral injection of amyloid-β peptide (25–35), and the effect of CHR on the learning and memory ability, the hippocampal neurons change, the ultrastructure of the hippocampal CA1 region, the protein levels of CaM, CaMKK, CaMKIV, p-CaMKIV and p-tau in the hippocampus of rats were studied. The results showed that CHR significantly improved the cognitive deficits, alleviated hippocampal neurons damage, prevented the ultrastructure alteration of neurons in hippocampal CA1 region, and reduced the protein levels of CaM, CaMKK, p-CaMKIV and p-tau in the hippocampus of AD rats. These results suggested that Chrysophanol could improve memory ability of Alzheimer’s disease rat by inhibiting tau hyperphosphorylation and the CaM–CaMKIV signal pathway.
Show more [+] Less [-]AGROVOC Keywords
Bibliographic information
This bibliographic record has been provided by National Agricultural Library